IQVIA Holdings Aktie
| 199,40USD | -0,86USD | -0,43% |
WKN DE: A2JSPM / ISIN: US46266C1053
Aktionärsstruktur
| Inhaber | in % |
|---|---|
| Freefloat | 99,17 |
| The Vanguard Group, Inc. | 11,61 |
| Vanguard Group, Inc. (Subfiler) | 10,60 |
| Harris Associates LP | 5,61 |
| Harris Associates LP | 5,37 |
| GIC Pte Ltd. (Investment Management) | 5,03 |
| State Street Corp. | 4,28 |
| BlackRock Fund Advisors | 3,46 |
| Vanguard Total Stock Market ETF | 3,01 |
| Vanguard 500 Index Fund | 2,53 |
| Geode Capital Management LLC | 2,26 |
| AllianceBernstein LP | 2,14 |
| BlackRock Institutional Trust Co. NA | 2,12 |
| Vanguard Mid Cap Index Fund | 2,02 |
| Canada Pension Plan Investment Board | 1,97 |
*Die Summe der Anteile kann 100% überschreiten, da bestimmte Anteilseigner zum Freefloat dazu gerechnet wurden.
Personal
| 2019 | 2020 | 2021 | 2022 | 2023 | |
|---|---|---|---|---|---|
| Personal am Ende des Jahres | 67 000 | 70 000 | 79 000 | 86 000 | 87 000 |
| Umsatz pro Mitarbeiter in Mio. EUR | 0,17 | 0,16 | 0,18 | 0,17 | 0,17 |
Bilanz (in Mio. USD) - Aktiva
| 2019 | 2020 | 2021 | 2022 | 2023 | |
|---|---|---|---|---|---|
| Summe Umlaufvermögen | 4 126 | 5 090 | 4 763 | 4 981 | 5 596 |
| Summe Anlagevermögen | 19 125 | 19 474 | 19 926 | 20 356 | 21 085 |
| Summe Aktiva | 23 251 | 24 564 | 24 689 | 25 337 | 26 681 |
Bilanz (in Mio. USD) - Passiva
| 2019 | 2020 | 2021 | 2022 | 2023 | |
|---|---|---|---|---|---|
| Summe Fremdkapital | 16 988 | 18 284 | 18 647 | 19 572 | 20 569 |
| Summe Eigenkapital | 6 263 | 6 280 | 6 042 | 5 765 | 6 112 |
| Summe Passiva | 23 251 | 24 564 | 24 689 | 25 337 | 26 681 |
Adresse
| 2400 Ellis Road, 27703 Durham | |
| Telefon | +1 (919) 998-2000 |
| Internet | http://www.iqvia.com |
Management
|
Ari Bousbib
Chairman, President & Chief Executive Officer |
|
Carol J. Burt
Independent Director |
|
Colleen A. Goggins
Independent Director |
|
Eric M. Sherbet
Secretary, Executive VP & General Counsel |
|
James A. Fasano
Independent Director |
|
James Grant Berkshire
Executive VP-Global Technology & Operations |
|
Jeffrey A. Spaeder
Chief Medical & Scientific Officer |
|
Joanne M. Hackett
Head-Genomic & Precision Medicine |
|
John G. Danhakl
Independent Director |
|
John M. Leonard
Lead Independent Director |
|
John P. Connaughton
Independent Director |
|
Karl Guenault
Chief Information Officer & Senior Vice President |
|
Keriann Cherofsky
Chief Accounting Officer, Senior VP & Controller |
|
Leslie Wims Morris
Independent Director |
|
Michael Stibilj
Vice President-Global Delivery Network |
|
Nick Childs
SVP-Investor Relations & Treasury |
|
Ronald Earl Bruehlman
Chief Financial Officer & Executive Vice President |
|
Sanjay Chikarmane
Chief Product Officer |
|
Sheila A. Stamps
Independent Director |
|
Todd Benjamin Sisitsky
Independent Director |
|
Trudy Stein
Chief Human Resources Officer & Executive VP |
|
W. Richard Staub
President-Research & Development Solutions |
ETF-Sparplan
Oskar ist der einfache und intelligente ETF-Sparplan. Er übernimmt die ETF-Auswahl, ist steuersmart, transparent und kostengünstig.
